Evidence map›Paper›PMID 26218228›Full record

Trial reportPloS one2015

Direct versus Indirect Treatment for Preschool Children who Stutter: The RESTART Randomized Trial.

Caroline de Sonneville-Koedoot, Elly Stolk, Toni Rietveld, Marie-Christine Franken

Open access · goldAbstract readMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 2 pooled it
18.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 2 syntheses or guidelines pooled it, 175 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Lidcombe Program translation to community clinics in Australia and England.International journal of language & communication disorders · 2023
    Article
  10. Article
  11. Article
  12. Risk Factors for the Development of Persistent Stuttering: What Every Pediatrician Should Know.International journal of environmental research and public health · 2022
    Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Caroline de Sonneville-KoedootInstitute of Health Policy and Management, Erasmus University Rotterdam, Rotterdam, the Netherlands; Speech and Hearing Center, Department of Otorhinolaryngology, Sophia Children's Hospital, Erasmus University Medical Center, Rotterdam, the Netherlands.
Elly StolkInstitute of Health Policy and Management, Erasmus University Rotterdam, Rotterdam, the Netherlands.
Toni RietveldDepartment of Linguistics, Radboud University Nijmegen, Nijmegen, the Netherlands.
Marie-Christine FrankenSpeech and Hearing Center, Department of Otorhinolaryngology, Sophia Children's Hospital, Erasmus University Medical Center, Rotterdam, the Netherlands.
Erasmus University Rotterdam · NLErasmus MC · NLRadboud University Nijmegen · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveStuttering is a common childhood disorder. There is limited high quality evidence regarding options for best treatment. The aim of the study was to compare the effectiveness of direct treatment with indirect treatment in preschool children who stutter.

methodsIn this multicenter randomized controlled trial with an 18 month follow-up, preschool children who stutter who were referred for treatment were randomized to direct treatment (Lidcombe Program; n = 99) or indirect treatment (RESTART-DCM treatment; n = 100). Main inclusion criteria were age 3-6 years, ≥3% syllables stuttered (%SS), and time since onset ≥6 months. The primary outcome was the percentage of non-stuttering children at 18 months. Secondary outcomes included stuttering frequency (%SS), stuttering severity ratings by the parents and therapist, severity rating by the child, health-related quality of life, emotional and behavioral problems, and speech attitude.

resultsPercentage of non-stuttering children for direct treatment was 76.5% (65/85) versus 71.4% (65/91) for indirect treatment (Odds Ratio (OR), 0.6; 95% CI, 0.1-2.4, p = .42). At 3 months, children treated by direct treatment showed a greater decline in %SS (significant interaction time x therapy: β = -1.89; t(282.82) = -2.807, p = .005). At 18 months, stuttering frequency was 1.2% (SD 2.1) for direct treatment and 1.5% (SD 2.1) for indirect treatment. Direct treatment had slightly better scores on most other secondary outcome measures, but no differences between treatment approaches were significant.

conclusionsDirect treatment decreased stuttering more quickly during the first three months of treatment. At 18 months, however, clinical outcomes for direct and indirect treatment were comparable. These results imply that at 18 months post treatment onset, both treatments are roughly equal in treating developmental stuttering in ways that surpass expectations of natural recovery. Follow-up data are needed to confirm these findings in the longer term.

trial registrationisrctn.org ISRCTN24362190.

Indexed as

Behavior TherapySpeech TherapyChildChild, PreschoolEarly Intervention, EducationalFemaleFollow-Up StudiesHumansMaleQuality of LifeSpeech Production MeasurementStutteringTreatment Outcome

Identifiers

PMID26218228
PMCPMC4517884
OpenAlexW1913100533

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.